SCHEMBL22969650

SCHEMBL22969650

COC(=O)C1N[C@H](C)CC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
BRD4 O60885 1/20 0.37
KMT2A Q03164 2/20 0.33
MMP2 P08253 1/20 0.33
ANPEP P15144 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
KDM4E B2RXH2 2/20 0.33
TSHR P16473 2/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CYP1A2 P05177 1/20 0.32
HIF1A Q16665 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19520662 0.81 MAPK1 (0.41) KDM4E
SCHEMBL26041476 0.72 KDM4E (0.40) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL24346570 0.72 KDM4E (0.40) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL24346569 0.72 KDM4E (0.40) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL26041506 0.72 KDM4E (0.40) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL27347400 0.70 ALDH1A1 (0.36) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL4044008 0.67 MAPKAPK2 (0.43) ALDH1A1BRD4KMT2AMAPKAPK2CHRNB2
SCHEMBL2784766 0.66 BRD4 (0.44) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL3072002 0.65 KMT2A (0.43) ALDH1A1BRD4KMT2AMMP2ANPEP
SCHEMBL3072000 0.65 KMT2A (0.43) ALDH1A1BRD4KMT2AMMP2ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026047-A1 HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2021-02-11 WO disclosed